Dechao Yu

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

Theodore L. DeWeese, H. Van der Poel, S. Li et al. · PubMed · 2001 · 386 citations

Translational Medicine, Urology, Radiation Medicine +13

A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer

Eric J. Small, Michael A. Carducci, James M. Burke et al. · Molecular Therapy · 2006 · 243 citations · Full text

CG0070, a Conditionally Replicating Granulocyte Macrophage Colony-Stimulating Factor–Armed Oncolytic Adenovirus for the Treatment of Bladder Cancer

Nagarajan Ramesh, Ying Ge, David L. Ennist et al. · Clinical Cancer Research · 2006 · 234 citations

Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.

Dechao Yu, Gordon T. Sakamoto, Daniel Henderson · PubMed · 1999 · 193 citations

Human Kallikrein 2, Viral Replication, Genetics +20

Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.

Dechao Yu, Yu Chen, Jeanette Dilley et al. · PubMed · 2001 · 175 citations

Tumor Biology, Particles Cv787, Medicine +15